Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1950
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia ; day:2 ; month:8 ; year:2016 ; pages:1-11
Drugs ; (2.8.2016), 1-11
- Creator
-
Jamieson, Gene C.
- Contributor
-
Fox, Judith A.
Poi, Ming
Strickland, Stephen A.
SpringerLink (Online service)
- DOI
-
10.1007/s40265-016-0614-z
- URN
-
urn:nbn:de:1111-201608043945
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jamieson, Gene C.
- Fox, Judith A.
- Poi, Ming
- Strickland, Stephen A.
- SpringerLink (Online service)
Other Objects (12)
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Quinolone antibacterials
Genetic and pharmacologic strategies to overcome differentiation block in acute myeloid leukemia
Reduction of anticancer drug toxicity : pharmacologic, biologic, immunologic and gene therapeutic approaches ; 41 tables
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
Inhibiting quinolone biosynthesis of Burkholderia
Non-pharmacologic therapy of hypertension
The ternary gyrase-DNA-quinolone complex : from molecular modelling to understanding quinolone action and resistance
Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
AN EXPEDITIOUS SYNTHESIS OF QUINOLONE ANTIBACTERIALS
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Quinolone antibacterials
Genetic and pharmacologic strategies to overcome differentiation block in acute myeloid leukemia
Reduction of anticancer drug toxicity : pharmacologic, biologic, immunologic and gene therapeutic approaches ; 41 tables
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
Inhibiting quinolone biosynthesis of Burkholderia
Non-pharmacologic therapy of hypertension
The ternary gyrase-DNA-quinolone complex : from molecular modelling to understanding quinolone action and resistance
Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
AN EXPEDITIOUS SYNTHESIS OF QUINOLONE ANTIBACTERIALS
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Quinolone antibacterials
Genetic and pharmacologic strategies to overcome differentiation block in acute myeloid leukemia
Reduction of anticancer drug toxicity : pharmacologic, biologic, immunologic and gene therapeutic approaches ; 41 tables
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
Inhibiting quinolone biosynthesis of Burkholderia
Non-pharmacologic therapy of hypertension
The ternary gyrase-DNA-quinolone complex : from molecular modelling to understanding quinolone action and resistance
Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy